Published in J Clin Oncol on January 28, 2008
Adverse symptom event reporting by patients vs clinicians: relationships with clinical outcomes. J Natl Cancer Inst (2009) 5.05
Patient self-reports of symptoms and clinician ratings as predictors of overall cancer survival. J Natl Cancer Inst (2011) 2.56
Bevacizumab for advanced cervical cancer: patient-reported outcomes of a randomised, phase 3 trial (NRG Oncology-Gynecologic Oncology Group protocol 240). Lancet Oncol (2015) 2.29
Quality of life data as prognostic indicators of survival in cancer patients: an overview of the literature from 1982 to 2008. Health Qual Life Outcomes (2009) 2.05
Net clinical benefit analysis of radiation therapy oncology group 0525: a phase III trial comparing conventional adjuvant temozolomide with dose-intensive temozolomide in patients with newly diagnosed glioblastoma. J Clin Oncol (2013) 1.62
Scientific imperatives, clinical implications, and theoretical underpinnings for the investigation of the relationship between genetic variables and patient-reported quality-of-life outcomes. Qual Life Res (2010) 1.61
Patient-reported physical functioning predicts the success of hematopoietic cell transplantation (BMT CTN 0902). Cancer (2015) 1.48
Clinical trial end points for high-grade glioma: the evolving landscape. Neuro Oncol (2011) 1.42
Quality of life supersedes the classic prognosticators for long-term survival in locally advanced non-small-cell lung cancer: an analysis of RTOG 9801. J Clin Oncol (2009) 1.34
Relationship between deficits in overall quality of life and non-small-cell lung cancer survival. J Clin Oncol (2012) 1.33
Health-related quality of life and cancer clinical trials. Ther Adv Med Oncol (2011) 1.30
Measuring the symptom burden of lung cancer: the validity and utility of the lung cancer module of the M. D. Anderson Symptom Inventory. Oncologist (2011) 1.30
Longitudinal patient-reported performance status assessment in the cancer clinic is feasible and prognostic. J Oncol Pract (2011) 1.17
The After Breast Cancer Pooling Project: rationale, methodology, and breast cancer survivor characteristics. Cancer Causes Control (2011) 1.15
Pretreatment quality of life is an independent prognostic factor for overall survival in patients with advanced stage non-small cell lung cancer. J Thorac Oncol (2009) 1.12
Long-term follow-up and individual item analysis of quality of life assessments related to laparoscopic-assisted colectomy in the COST trial 93-46-53 (INT 0146). Ann Surg Oncol (2011) 1.09
Quality of life in adults with brain tumors: current knowledge and future directions. Neuro Oncol (2008) 1.09
Self-perceived quality of life predicts mortality risk better than a multi-biomarker panel, but the combination of both does best. BMC Med Res Methodol (2011) 1.09
Management of gastrointestinal symptoms in advanced cancer patients: the rapid learning cancer clinic model. Curr Opin Support Palliat Care (2010) 1.08
Patient-reported outcomes (PROs): putting the patient perspective in patient-centered outcomes research. Med Care (2013) 1.06
Improvement in self-reported physical health predicts longer survival among women with a history of breast cancer. Breast Cancer Res Treat (2010) 1.06
Methodological issues regarding power of classical test theory (CTT) and item response theory (IRT)-based approaches for the comparison of patient-reported outcomes in two groups of patients--a simulation study. BMC Med Res Methodol (2010) 1.06
A contextual approach to understanding breast cancer survivorship among Latinas. Psychooncology (2011) 1.05
Relationship between cytokine gene single nucleotide polymorphisms and symptom burden and quality of life in lung cancer survivors. Cancer (2010) 1.05
Prognostic value of symptom burden for overall survival in patients receiving chemotherapy for advanced nonsmall cell lung cancer. Cancer (2010) 1.03
The establishment of the GENEQOL consortium to investigate the genetic disposition of patient-reported quality-of-life outcomes. Twin Res Hum Genet (2009) 1.03
Quality of life in elderly patients with acute myeloid leukemia: patients may be more accurate than physicians. Haematologica (2011) 1.03
Mapping the QLQ-C30 quality of life cancer questionnaire to EQ-5D patient preferences. Eur J Health Econ (2010) 1.02
Through the lens of culture: quality of life among Latina breast cancer survivors. Breast Cancer Res Treat (2012) 1.01
Effects of adjuvant chemotherapy on recurrence, survival, and quality of life in stage II colon cancer patients: a 24-month follow-up. Support Care Cancer (2015) 1.00
Cancer-related fatigue: epidemiology, pathogenesis, diagnosis, and treatment. Dtsch Arztebl Int (2012) 0.99
Integrating Patient-Reported Outcome Measures into Routine Cancer Care: Cancer Patients' and Clinicians' Perceptions of Acceptability and Value. EGEMS (Wash DC) (2015) 0.97
Health-related quality of life in ovarian cancer patients and its impact on clinical management. Expert Rev Pharmacoecon Outcomes Res (2011) 0.97
Upper-body morbidity following breast cancer treatment is common, may persist longer-term and adversely influences quality of life. Health Qual Life Outcomes (2010) 0.97
Does change in health-related quality of life score predict survival? Analysis of EORTC 08975 lung cancer trial. Br J Cancer (2014) 0.95
Health-related quality of life and inflammatory markers in malignant pleural mesothelioma. Support Care Cancer (2012) 0.95
The association between clinician-based common terminology criteria for adverse events (CTCAE) and patient-reported outcomes (PRO): a systematic review. Support Care Cancer (2016) 0.92
Prospective evaluation of quality of life effects in patients undergoing palliative radiotherapy for brain metastases. BMC Cancer (2012) 0.91
Long-term course of pain in breast cancer survivors: a 4-year longitudinal study. Breast Cancer Res Treat (2011) 0.90
Self-reported health-related quality of life is an independent predictor of chemotherapy treatment benefit and toxicity in women with advanced breast cancer. Br J Cancer (2010) 0.89
Preoperative and early postoperative quality of life predict survival in potentially curable patients with esophageal cancer. Ann Surg Oncol (2009) 0.88
Estimating prognosis and palliation based on tumour marker CA 19-9 and quality of life indicators in patients with advanced pancreatic cancer receiving chemotherapy. Br J Cancer (2010) 0.87
Normative data and clinically significant effect sizes for single-item numerical linear analogue self-assessment (LASA) scales. Health Qual Life Outcomes (2014) 0.87
An evaluation of the factors that affect the health-related quality of life of children following myelosuppressive chemotherapy. Support Care Cancer (2010) 0.86
Genetic variations and patient-reported quality of life among patients with lung cancer. J Clin Oncol (2012) 0.86
Metrics to assess quality of life after management of early-stage lung cancer. Cancer J (2011) 0.86
Prognostic significance of pre-transplant quality of life in allogeneic hematopoietic cell transplantation recipients. Bone Marrow Transplant (2015) 0.85
Overview of the Spinal Cord Injury--Quality of Life (SCI-QOL) measurement system. J Spinal Cord Med (2015) 0.84
Use of patient-reported outcomes in randomized, double-blind, placebo-controlled clinical trials. Med Care (2011) 0.83
Identifying the target NSCLC patient for maintenance therapy: an analysis from a placebo-controlled, phase III trial of maintenance pemetrexed (H3E-MC-JMEN). Ann Oncol (2013) 0.83
Postoperative deterioration in health related quality of life as predictor for survival in patients with glioblastoma: a prospective study. PLoS One (2011) 0.82
Baseline quality of life factors predict long term survival after elective resection for colorectal cancer. Int J Surg Oncol (2013) 0.81
Quality of life measures as a preliminary clinical indicator in patients with primary brain tumors. Surg Neurol Int (2013) 0.81
Subcutaneous bortezomib for multiple myeloma treatment: patients' benefits. Patient Prefer Adherence (2014) 0.80
Nomogram for predicting symptom severity during radiation therapy for head and neck cancer. Otolaryngol Head Neck Surg (2014) 0.80
Management of Patient-Reported Outcome (PRO) Alerts in Clinical Trials: A Cross Sectional Survey. PLoS One (2016) 0.80
Collaborative Care in NSCLC; the Role of Early Palliative Care. Front Oncol (2014) 0.80
Oncology patient-reported claims: maximising the chance for success. Ecancermedicalscience (2011) 0.80
Patient-reported outcomes as end points and outcome indicators in solid tumours. Nat Rev Clin Oncol (2015) 0.80
Depressive symptoms during the first chemotherapy cycle predict mortality in patients with advanced non-small cell lung cancer. Support Care Cancer (2010) 0.79
Optimal cut points for quality of life questionnaire-core 30 (QLQ-C30) scales: utility for clinical trials and updates of prognostic systems in advanced hepatocellular carcinoma. Oncologist (2014) 0.79
Quality of Life and Mortality of Long-Term Colorectal Cancer Survivors in the Seattle Colorectal Cancer Family Registry. PLoS One (2016) 0.79
Using patient-reported health status to improve prognostic assessment in patients with acute myeloid leukemia: current challenges and future applications. Haematologica (2013) 0.78
A longitudinal study of the role of patient-reported outcomes on survival prediction of palliative cancer inpatients in Taiwan. Support Care Cancer (2009) 0.78
Prediction of long-term mortality by preoperative health-related quality-of-life in elderly onco-surgical patients. PLoS One (2014) 0.77
Patient-reported pain and other quality of life domains as prognostic factors for survival in a phase III clinical trial of patients with advanced breast cancer. Health Qual Life Outcomes (2016) 0.77
Examining health-related quality of life patterns in women with breast cancer. Qual Life Res (2017) 0.76
Baseline health perceptions, dysphagia, and survival in patients with head and neck cancer. Cancer (2013) 0.76
Patient-reported utilities in advanced or metastatic melanoma, including analysis of utilities by time to death. Health Qual Life Outcomes (2014) 0.76
Prognostic value of patient-reported symptom interference in patients with late-stage lung cancer. Qual Life Res (2013) 0.76
Key issues affecting quality of life and patient-reported outcomes in prostate cancer: an analysis conducted in 2128 patients with initial psychometric assessment of the prostate cancer symptom scale (PCSS). BMJ Support Palliat Care (2017) 0.76
Detecting short-term change and variation in health-related quality of life: within- and between-person factor structure of the SF-36 health survey. Health Qual Life Outcomes (2015) 0.75
Prognostic values of EORTC QLQ-C30 and QLQ-HCC18 index-scores in patients with hepatocellular carcinoma - clinical application of health-related quality-of-life data. BMC Cancer (2017) 0.75
Reliability and validity of the Cancer Therapy Satisfaction Questionnaire in lung cancer. Qual Life Res (2015) 0.75
The prognostic value of pre-diagnosis health-related quality of life on survival: a prospective cohort study of older Americans with lung cancer. Qual Life Res (2017) 0.75
A Novel Digital Patient-Reported Outcome Platform for Head and Neck Oncology Patients-A Pilot Study. Clin Med Insights Ear Nose Throat (2016) 0.75
Assessment of patient-reported outcomes in patients with melanoma. Surg Oncol Clin N Am (2011) 0.75
Quality of life after cancer-How the extent of impairment is influenced by patient characteristics. BMC Cancer (2016) 0.75
Longitudinal patterns of cancer patient reported outcomes in end of life care predict survival. Support Care Cancer (2015) 0.75
Associations Between Fetal Growth and Self-Perceived Health Throughout Adulthood: A Co-twin Control Study. Behav Genet (2016) 0.75
Prognostic value of quality of life score in disease-free survivors of surgically-treated lung cancer. BMC Cancer (2016) 0.75
Predictors of health-related quality of life and association with survival may identify colorectal cancer patients at high risk of poor prognosis. Qual Life Res (2016) 0.75
Preoperative cognitive function predicts survival in patients with resectable pancreatic ductal adenocarcinoma. HPB (Oxford) (2015) 0.75
End points of clinical trials in metastatic castration-resistant prostate cancer: A systematic review. World J Methodol (2014) 0.75
Health-Related Quality of Life and Survival of Cholangiocarcinoma Patients in Northeastern Region of Thailand. PLoS One (2016) 0.75
Health Behaviors in Cervical Cancer Survivors and Associations with Quality of Life. Clin Ther (2016) 0.75
Comparison of generic and lung cancer-specific quality of life instruments for predictive ability of survival in patients with advanced lung cancer. Springerplus (2016) 0.75
Systems Chronotherapeutics. Pharmacol Rev (2017) 0.75
Factors influencing the health-related quality of life of Chinese advanced cancer patients and their spousal caregivers: a cross-sectional study. BMC Palliat Care (2016) 0.75
The prognostic performance of adding patient-reported outcomes to the MASCC risk index to identify low-risk febrile neutropenia patients with solid tumors and lymphomas. Support Care Cancer (2017) 0.75
SCARA5 plays a critical role in the progression and metastasis of breast cancer by inactivating the ERK1/2, STAT3, and AKT signaling pathways. Mol Cell Biochem (2017) 0.75
Patient-reported outcome reference values for patients after kidney transplantation. Wien Klin Wochenschr (2013) 0.75
Value of quality of life analysis in liver cancer: A clinician's perspective. World J Hepatol (2017) 0.75
Quality of life independently predicts long-term mortality but not vascular events: the Northern Manhattan Study. Qual Life Res (2017) 0.75
Italian version of the M.D. Anderson Symptom Inventory-Head and Neck Module: linguistic validation. Support Care Cancer (2015) 0.75
Reducing Uncertainty: Predictors of Stopping Chemotherapy Early and Shortened Survival Time in Platinum Resistant/Refractory Ovarian Cancer-The GCIG Symptom Benefit Study. Oncologist (2017) 0.75
An Evaluation of Artificial Neural Networks in Predicting Pancreatic Cancer Survival. J Gastrointest Surg (2017) 0.75
Quality of life is significantly associated with survival in women with advanced epithelial ovarian cancer: An ancillary data analysis of the NRG Oncology/Gynecologic Oncology Group (GOG-0218) study. Gynecol Oncol (2017) 0.75
Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials. Lancet Oncol (2009) 2.64
Patient self-reports of symptoms and clinician ratings as predictors of overall cancer survival. J Natl Cancer Inst (2011) 2.56
Health-related quality of life in patients with glioblastoma: a randomised controlled trial. Lancet Oncol (2005) 2.26
The development of the EORTC QLQ-C15-PAL: a shortened questionnaire for cancer patients in palliative care. Eur J Cancer (2005) 1.97
An international field study of the EORTC QLQ-PR25: a questionnaire for assessing the health-related quality of life of patients with prostate cancer. Eur J Cancer (2008) 1.95
What is the effect of systemic anticancer treatment on cognitive function? Lancet Oncol (2004) 1.89
An international validation study of the EORTC brain cancer module (EORTC QLQ-BN20) for assessing health-related quality of life and symptoms in brain cancer patients. Eur J Cancer (2010) 1.84
Health-related quality of life in patients treated for anaplastic oligodendroglioma with adjuvant chemotherapy: results of a European Organisation for Research and Treatment of Cancer randomized clinical trial. J Clin Oncol (2007) 1.72
Smokers who try e-cigarettes to quit smoking: findings from a multiethnic study in Hawaii. Am J Public Health (2013) 1.71
Net clinical benefit analysis of radiation therapy oncology group 0525: a phase III trial comparing conventional adjuvant temozolomide with dose-intensive temozolomide in patients with newly diagnosed glioblastoma. J Clin Oncol (2013) 1.62
Patient-reported outcomes in randomized clinical trials: development of ISOQOL reporting standards. Qual Life Res (2012) 1.62
Translation procedures for standardised quality of life questionnaires: The European Organisation for Research and Treatment of Cancer (EORTC) approach. Eur J Cancer (2007) 1.62
Transfusions at home in patients with myelodysplastic syndromes. Leuk Res (2012) 1.59
Health-related quality of life in survivors of locally advanced breast cancer: an international randomised controlled phase III trial. Lancet Oncol (2005) 1.48
Do quality-of-life randomized clinical trials support clinicians in their decision-making? J Clin Oncol (2002) 1.45
Multicollinearity in prognostic factor analyses using the EORTC QLQ-C30: identification and impact on model selection. Stat Med (2002) 1.28
Review on quality of life issues in patients with primary brain tumors. Oncologist (2010) 1.24
Does a patient's self-reported health-related quality of life predict survival beyond key biomedical data in advanced colorectal cancer? Eur J Cancer (2005) 1.20
Health-related quality of life parameters as prognostic factors in a nonmetastatic breast cancer population: an international multicenter study. J Clin Oncol (2004) 1.17
Patient-reported outcomes after neoadjuvant chemoradiotherapy for rectal cancer: a multicenter prospective observational study. Ann Surg (2011) 1.16
Quality of life after palliative radiation therapy for patients with painful bone metastases: results of an international study validating the EORTC QLQ-BM22. Int J Radiat Oncol Biol Phys (2012) 1.15
Minimal important differences for interpreting health-related quality of life scores from the EORTC QLQ-C30 in lung cancer patients participating in randomized controlled trials. Support Care Cancer (2010) 1.15
International field testing of the reliability and validity of the EORTC QLQ-BM22 module to assess health-related quality of life in patients with bone metastases. Cancer (2011) 1.14
Health related quality of life in prostate carcinoma patients: a systematic review of randomized controlled trials. Cancer (2003) 1.14
A simulation study provided sample size guidance for differential item functioning (DIF) studies using short scales. J Clin Epidemiol (2008) 1.12
Assessing HRQOL: a neglected issue for high-grade glioma. Lancet Oncol (2003) 1.11
Differential item functioning (DIF) analyses of health-related quality of life instruments using logistic regression. Health Qual Life Outcomes (2010) 1.11
A global analysis of multitrial data investigating quality of life and symptoms as prognostic factors for survival in different tumor sites. Cancer (2013) 1.10
Is baseline quality of life useful for predicting survival with hormone-refractory prostate cancer? A pooled analysis of three studies of the European Organisation for Research and Treatment of Cancer Genitourinary Group. J Clin Oncol (2004) 1.09
The case for an international patient-reported outcomes measurement information system (PROMIS®) initiative. Health Qual Life Outcomes (2013) 1.08
Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-OG25, to assess health-related quality of life in patients with cancer of the oesophagus, the oesophago-gastric junction and the stomach. Eur J Cancer (2007) 1.07
The European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire for patients with bone metastases: the EORTC QLQ-BM22. Eur J Cancer (2008) 1.07
Fatigue and quality of life: lessons from the real world. Oncologist (2003) 1.02
Development of an EORTC quality of life phase III module measuring cancer-related fatigue (EORTC QLQ-FA13). Psychooncology (2012) 1.01
Health-related quality of life in non-small-cell lung cancer: an update of a systematic review on methodologic issues in randomized controlled trials. J Clin Oncol (2011) 1.00
The relationship between overall quality of life and its subdimensions was influenced by culture: analysis of an international database. J Clin Epidemiol (2008) 0.98
EORTC QLQ-INFO26: a questionnaire to assess information given to cancer patients a preliminary analysis in eight countries. Psychooncology (2007) 0.98
Imatinib treatment in chronic myelogenous leukemia: What have we learned so far? Cancer Lett (2010) 0.98
Long-term health-related quality of life evaluated more than 20 years after hematopoietic stem cell transplantation for thalassemia. Blood (2013) 0.98
Prognostic value of health-related quality-of-life data in predicting survival in patients with anaplastic oligodendrogliomas, from a phase III EORTC brain cancer group study. J Clin Oncol (2007) 0.97
Health-related quality of life in non-small-cell lung cancer: methodologic issues in randomized controlled trials. J Clin Oncol (2003) 0.97
Attitudes of young patients with breast cancer toward fertility loss related to adjuvant systemic therapies. EORTC study 10002 BIG 3-98. Psychooncology (2013) 0.97
Health related quality of life in Middle Eastern children with beta-thalassemia. BMC Blood Disord (2012) 0.95
Treatment satisfaction as an outcome measure in cancer clinical treatment trials. Expert Rev Pharmacoecon Outcomes Res (2002) 0.94
Predictive factors for overall quality of life in patients with advanced cancer. Support Care Cancer (2013) 0.94
Health-related quality of life and symptom assessment in clinical research of patients with hematologic malignancies: where are we now and where do we go from here? Haematologica (2007) 0.93
Health-related quality of life and cognitive functioning in long-term anaplastic oligodendroglioma and oligoastrocytoma survivors. J Neurooncol (2013) 0.93
Radiotherapy in conjunction with intravenous infusion of 180 mg of disodium pamidronate in management of osteolytic metastases from breast cancer: clinical evaluation, biochemical markers, quality of life, and monitoring of recalcification using assessments of gray-level histogram in plain radiographs. Int J Radiat Oncol Biol Phys (2003) 0.91
Evaluating health-related quality of life and symptom burden in brain tumour patients: instruments for use in experimental trials and clinical practice. Curr Opin Neurol (2008) 0.91
Moving towards patient-centered decision-making in chronic myeloid leukemia: assessment of quality of life and symptom burden. Haematologica (2014) 0.90
Prospective assessment of health-related quality of life in pediatric patients with beta-thalassemia following hematopoietic stem cell transplantation. Biol Blood Marrow Transplant (2010) 0.90
Differential item functioning (DIF) in the EORTC QLQ-C30: a comparison of baseline, on-treatment and off-treatment data. Qual Life Res (2009) 0.90
Different perception of surgical risks between physicians and patients undergoing laparoscopic cholecystectomy. Surg Laparosc Endosc Percutan Tech (2009) 0.89
When a parent has cancer: challenges to patients, their families and health providers. Expert Rev Pharmacoecon Outcomes Res (2012) 0.88
Understanding the EORTC QLQ-BM22, the module for patients with bone metastases. Expert Rev Pharmacoecon Outcomes Res (2009) 0.88
Health-related quality of life outcomes in disease-free survivors of mid-low rectal cancer after curative surgery. Ann Surg Oncol (2008) 0.87
Toward a clearer understanding of the prognostic value of health-related quality-of-life parameters in breast cancer. J Clin Oncol (2005) 0.87
The reasons for betel-quid chewing scale: assessment of factor structure, reliability, and validity. BMC Oral Health (2014) 0.86
Intention to quit betel quid: a comparison of betel quid chewers and cigarette smokers. Oral Health Dent Manag (2014) 0.86
Patients' and health care professionals' evaluation of health-related quality of life issues in bone metastases. Eur J Cancer (2009) 0.86
Determinants of quality of life in advanced cancer patients with bone metastases undergoing palliative radiation treatment. Support Care Cancer (2013) 0.85
Validation of the Polish version of the EORTC QLQ-BM22 module for the assessment of health-related quality of life in patients with bone metastases. Qual Life Res (2013) 0.85
Controlled-release oxycodone for the treatment of bortezomib-induced neuropathic pain in patients with multiple myeloma. Support Care Cancer (2012) 0.83
Health-related quality of life, faecal continence and bowel function in rectal cancer patients after chemoradiotherapy followed by radical surgery. Support Care Cancer (2009) 0.83
Standards are needed for quality of life clinical trials. BMJ (2002) 0.83
The reliability and validity of the Iranian version of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire for patients with Bone Metastases: the EORTC QLQ-BM22. Expert Rev Pharmacoecon Outcomes Res (2013) 0.82
An international prospective study establishing minimal clinically important differences in the EORTC QLQ-BM22 and QLQ-C30 in cancer patients with bone metastases. Support Care Cancer (2012) 0.82
Comparison of three shortened questionnaires for assessment of quality of life in advanced cancer. J Palliat Med (2014) 0.82
Validation of the Polish version of the EORTC QLQ-OV28 module for the assessment of health-related quality of life in women with ovarian cancer. Expert Rev Pharmacoecon Outcomes Res (2013) 0.82
Trends in translation requests and arising issues regarding cultural adaptation. Expert Rev Pharmacoecon Outcomes Res (2011) 0.81
Health-related quality of life and symptom research in glioblastoma multiforme patients. Expert Rev Pharmacoecon Outcomes Res (2005) 0.81
Health-related quality of life in patients with brain tumors: limitations and additional outcome measures. Curr Neurol Neurosci Rep (2013) 0.81
Cross-cultural development of an EORTC questionnaire to assess health-related quality of life in patients with testicular cancer: the EORTC QLQ-TC26. Qual Life Res (2012) 0.80
Patient-reported outcomes for the myelodysplastic syndromes: a new MDS-specific measure of quality of life. Blood (2014) 0.80
Development, characteristics and validity of the EORTC QLQ-PR25 and the FACT-P for assessment of quality of life in prostate cancer patients. J Comp Eff Res (2014) 0.80
Health-related quality of life and symptom assessment in patients with myelodysplastic syndromes. Expert Rev Hematol (2009) 0.80
Oral-health-related quality of life in patients with cancer: cultural adaptation and the psychometric testing of the Persian version of EORTC QLQ-OH17. Support Care Cancer (2014) 0.79
The practical impact of differential item functioning analyses in a health-related quality of life instrument. Qual Life Res (2009) 0.79
Adherence to treatment is a complex and multifaceted issue that can substantially alter the outcome of chronic myeloid leukemia patients treated with tyrosine kinase inhibitors. Leuk Res (2012) 0.79
Cross-cultural development of the EORTC QLQ-SWB36: a stand-alone measure of spiritual wellbeing for palliative care patients with cancer. Palliat Med (2012) 0.79
Comparison of the EORTC QLQ-BN20 and the FACT-Br quality of life questionnaires for patients with primary brain cancers: a literature review. Support Care Cancer (2014) 0.78
Joint modeling of longitudinal health-related quality of life data and survival. Qual Life Res (2014) 0.78
EORTC QLQ-BR23 and FACT-B for the assessment of quality of life in patients with breast cancer: a literature review. J Comp Eff Res (2015) 0.78
Understanding cervical cancer prevention and screening in Chuukese women in Hawaii. Hawaii Med J (2010) 0.78
Implementing patient-reported health-related quality-of-life data in cancer routine practice to improve accuracy of prognosis. Are we there yet? Expert Rev Pharmacoecon Outcomes Res (2009) 0.78